JAWM
APTO

J. Arnold Wealth Management’s Aptose Biosciences, Inc. APTO Stock Holding History

J. Arnold Wealth Management’s Portfolio APTO Stock Details APTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-88
Closed -$25.2K – 59
2023
Q1 		$25.2K Buy
88
+5
+6% +$1.45K 0.01% 46
2022
Q4 		$21.7K Buy
83
+43
+108% +$11.6K 0.01% 67
2022
Q3 		$11K Buy
40
+9
+29% +$3.1K 0.01% 41
2022
Q2 		$10K Buy
+31
New +$14.8K 0.01% 35
2021
Q4 		– Sell
-31
Closed -$31K – 70
2021
Q3 		$31K Sell
31
-2
-6% -$2.5K 0.01% 49
2021
Q2 		$49K Buy
33
+7
+27% +$15.2K 0.02% 61
2021
Q1 		$70K Sell
26
-9
-26% -$17.8K 0.04% 55
2020
Q4 		$68K Sell
35
-5
-13% -$11.7K 0.04% 51
2020
Q3 		$109K Buy
40
+6
+18% +$15K 0.08% 37
2020
Q2 		$97K Buy
34
+4
+13% +$12.9K 0.08% 47
2020
Q1 		$80K Sell
30
-10
-25% -$29.8K 0.23% 21
2019
Q4 		$102K Buy
+40
New +$52.1K 0.13% 61

Other funds holding APTO

DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return
AC
Annandale Capital Dallas, Texas $709M AUM 11.03% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $33.7B AUM 35.49% 1-Year Est. Return
US Bancorp
US Bancorp Minneapolis, Minnesota $82.4B AUM 19.69% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

J. Arnold Wealth Management's APTO Position: Q2 2023 in Review

J. Arnold Wealth Management sold out of Aptose Biosciences, Inc. (APTO) in Q2 2023, closing a stake of 88 shares — an estimated $25.2K sold.

J. Arnold Wealth Management first reported a position in APTO in Q4 2019 and held it in 12 quarters. The position peaked at $109K in Q3 2020. 24 funds tracked by Wall St. Rank hold APTO as of Q2 2023.

  • J. Arnold Wealth Management reported no remaining Aptose Biosciences, Inc. position as of Q2 2023 after selling out during the quarter.
  • J. Arnold Wealth Management sold 88 Aptose Biosciences, Inc. shares in Q2 2023, an estimated $25.2K.
  • J. Arnold Wealth Management first reported a position in Aptose Biosciences, Inc. in Q4 2019 and held it in 12 quarters.
  • J. Arnold Wealth Management's Aptose Biosciences, Inc. position peaked at $109K in Q3 2020.
  • 24 funds tracked by Wall St. Rank held Aptose Biosciences, Inc. as of Q2 2023.

Based on J. Arnold Wealth Management's 13F filing for Q2 2023, filed 9 Aug 2023.